Interpretation of <i>Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) Guidelines for the Prevention and Control of Meticillin-resistant Staphylococcus aureus (MRSA) in Healthcare Facilities</i>_West China Medical Journal

Authors：

WANG Ying ^1,2 ,  QIAO Fu ³

1. Infection Prevention and Control Department, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P. R. China;
2. Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, Hubei 430071, P. R. China;
3. Department of Infection Control, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

QIAO Fu, Email: qiaofu2005@gmail.com

Keywords：

Staphylococcus aureus; methicillin resistance; infection prevention and control; guideline

DOI：

10.7507/1002-0179.202202058

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Methicillin-resistant Staphylococcus aureus is one of the important pathogens of healthcare-associated infections. In order to prevent and control the transmission of the drug-resistant organism in healthcare facilities, the Healthcare Infection Society and the Infection Prevention Society jointly conducted the guidelines for the prevention and control of methicillin-resistant Staphylococcus aureus in 2021. This article introduces the guide from the background, preparation process, main prevention and control measures and further studies, and compares the guidelines with the current prevention and control measures in China, so as to provide a methodological reference for preparation of the guide for domestic infection prevention and control practitioners, and provide evidence-based prevention and control strategies for clinical practice.

Citation： WANG Ying, QIAO Fu. Interpretation of Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) Guidelines for the Prevention and Control of Meticillin-resistant Staphylococcus aureus (MRSA) in Healthcare Facilities. West China Medical Journal, 2022, 37(3): 339-343. doi: 10.7507/1002-0179.202202058 Copy

1.	Coia JE, Duckworth GJ, Edwards DI, et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect, 2006, 63(Suppl 1): S1-S44.
2.	Coia JE, Wilson JA, Bak A, et al. Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect, 2021, 118(Suppl 1): S1-S39.
3.	中国细菌耐药监测网 CHINET. 251135 株临床分离菌株主要菌种分布. (2021-02-16)[2022-01-01]. http://www.chinets.com/Data/AntibioticDrugFast.
4.	Luzum M, Sebolt J, Chopra V. Catheter-associated urinary tract infection, Clostridioides difficile colitis, central line-associated bloodstream infection, and methicillin-resistant Staphylococcus aureus. Med Clin North Am, 2020, 104(4): 663-679.
5.	Dadashi M, Nasiri MJ, Fallah F, et al. Methicillin-resistant Staphylococcus aureus (MRSA) in Iran: a systematic review and meta-analysis. J Glob Antimicrob Resist, 2018, 12: 96-103.
6.	Kalil AC, Van Schooneveld TC, Fey PD, et al. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. JAMA, 2014, 312(15): 1552-1564.
7.	Turner NA, Sharma-Kuinkel BK, Maskarinec SA, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol, 2019, 17(4): 203-218.
8.	Lee AS, de Lencastre H, Garau J, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers, 2018, 4: 18033.
9.	Brown NM, Goodman AL, Horner C, et al. Treatment of meticillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK. JAC-Antimicrob Resist, 2021, 3: dlaa114.
10.	Luk S, Chow VCY, Yu KCH, et al. Effectiveness of antimicrobial hospital curtains on reducing bacterial contamination: a multicenter study. Infect Control Hospital Epidemiol, 2018, 40(2): 164e70.
11.	杨启文, 吴安华, 胡必杰, 等. 临床重要耐药菌感染传播防控策略专家共识. 中国感染控制杂志, 2021, 20(1): 1-14.
12.	Srigley JA, Furness CD, Gardam M. Interventions to improve patient hand hygiene: a systematic review. J Hosp Infect, 2016, 94(1): 23-29.
13.	Zhang ZG, Chen F, Chen JZ. Introducing an antibiotic stewardship program in a pediatric center in China. World J Pediatr, 2018, 14(3): 274-279.
14.	Ma X, Xie J, Yang Y, et al. Antimicrobial stewardship of Chinese ministry of health reduces multidrug-resistant organism isolates in critically ill patients: a pre-post study from a single center. BMC Infect Dis, 2016, 16(1): 704.
15.	Plantinga NL, Wittekamp BH, van Duijn PJ, et al. Fighting antibiotic resistance in the intensive care unit using antibiotics. Future Microbiol, 2015, 10(3): 391-406.

1. Coia JE, Duckworth GJ, Edwards DI, et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect, 2006, 63(Suppl 1): S1-S44.
2. Coia JE, Wilson JA, Bak A, et al. Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect, 2021, 118(Suppl 1): S1-S39.
3. 中国细菌耐药监测网 CHINET. 251135 株临床分离菌株主要菌种分布. (2021-02-16)[2022-01-01]. http://www.chinets.com/Data/AntibioticDrugFast.
4. Luzum M, Sebolt J, Chopra V. Catheter-associated urinary tract infection, Clostridioides difficile colitis, central line-associated bloodstream infection, and methicillin-resistant Staphylococcus aureus. Med Clin North Am, 2020, 104(4): 663-679.
5. Dadashi M, Nasiri MJ, Fallah F, et al. Methicillin-resistant Staphylococcus aureus (MRSA) in Iran: a systematic review and meta-analysis. J Glob Antimicrob Resist, 2018, 12: 96-103.
6. Kalil AC, Van Schooneveld TC, Fey PD, et al. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. JAMA, 2014, 312(15): 1552-1564.
7. Turner NA, Sharma-Kuinkel BK, Maskarinec SA, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol, 2019, 17(4): 203-218.
8. Lee AS, de Lencastre H, Garau J, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers, 2018, 4: 18033.
9. Brown NM, Goodman AL, Horner C, et al. Treatment of meticillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK. JAC-Antimicrob Resist, 2021, 3: dlaa114.
10. Luk S, Chow VCY, Yu KCH, et al. Effectiveness of antimicrobial hospital curtains on reducing bacterial contamination: a multicenter study. Infect Control Hospital Epidemiol, 2018, 40(2): 164e70.
11. 杨启文, 吴安华, 胡必杰, 等. 临床重要耐药菌感染传播防控策略专家共识. 中国感染控制杂志, 2021, 20(1): 1-14.
12. Srigley JA, Furness CD, Gardam M. Interventions to improve patient hand hygiene: a systematic review. J Hosp Infect, 2016, 94(1): 23-29.
13. Zhang ZG, Chen F, Chen JZ. Introducing an antibiotic stewardship program in a pediatric center in China. World J Pediatr, 2018, 14(3): 274-279.
14. Ma X, Xie J, Yang Y, et al. Antimicrobial stewardship of Chinese ministry of health reduces multidrug-resistant organism isolates in critically ill patients: a pre-post study from a single center. BMC Infect Dis, 2016, 16(1): 704.
15. Plantinga NL, Wittekamp BH, van Duijn PJ, et al. Fighting antibiotic resistance in the intensive care unit using antibiotics. Future Microbiol, 2015, 10(3): 391-406.

West China Medical Journal

Interpretation of Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) Guidelines for the Prevention and Control of Meticillin-resistant Staphylococcus aureus (MRSA) in Healthcare Facilities

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content